Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	95.37	89.88	46.01
Graham Fair Price	2.32	29.45	28.78
PEG	21082.87	-7.25	0.03
Price/Book	26.35	5.11	4.05
Price/Cash Flow	530.02	267.23	42.42
Prices/Earnings	42.71	24.82	17.39
Price/Sales	66.71	9.51	5.70
Price/FCF	530.02	267.23	42.42
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.21	0.28	0.26
Operating Margin	-26.36	0.08	0.10
ROA	-3.98	< 0.005	< 0.005
ROE	0.06	0.05	-11.46
ROIC	0.03	0.02	-36.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.10	-78.36
Dividends QOQ	-0.42	-0.03	93.91
EBIT QOQ	11.44	-0.39	-96.58
EPS QOQ	5.08	-0.03	-99.33
FCF QOQ	0.84	-0.78	-6.70
Revenue QOQ	0.12	-0.17	44.95
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	103.33	137.58	33.15
Days Sales Outstanding (DSO)	80.77	93.34	15.55
Inventory Turnover	0.87	0.65	-24.90
Debt/Capitalization	0.46	0.41	-10.63
Quick Ratio	0.79	0.76	-3.58
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.16	27.36	8.75
Cash	20.84	20.33	-2.43
Capex	-0.49	-0.39	20.78
Free Cash Flow	2.40	0.52	-78.19
Revenue	17.85	14.71	-17.58
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.18	1.17	-0.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.35	2.29	-2.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating